Literature DB >> 15103024

HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.

Joël LeMaoult1, Irène Krawice-Radanne, Jean Dausset, Edgardo D Carosella.   

Abstract

We recently reported that HLA-G1-transfected antigen-presenting cells (HLA-G1+ APCs) were capable of inhibiting alloproliferative responses. The aim of the present work was to further study the function and the mechanisms of action of HLA-G1+ APCs. We show here that HLA-G1+ APCs are immunoinhibitory cells that (i) inhibit the proliferation of CD4+ T cells, (ii) shed HLA-G1 molecules that might provide extra, non-antigen-specific, inhibitory or proapoptotic signals, (iii) induce CD4+ T cell anergy, or at least long-term unresponsiveness, and (iv) cause the differentiation of CD4+ T cells into suppressive cells. Thus, HLA-G+ APCs might (i) be involved in the direct suppression of immune responses and (ii) contribute to long-term efficient immune escape or tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103024      PMCID: PMC406466          DOI: 10.1073/pnas.0401922101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Modulation of HLA-G antigens expression in myelomonocytic cells.

Authors:  M Onno; G Le Friec; C Pangault; L Amiot; V Guilloux; B Drénou; S Caulet-Maugendre; P André; R Fauchet
Journal:  Hum Immunol       Date:  2000-11       Impact factor: 2.850

2.  Implication of HLA-G molecule in heart-graft acceptance.

Authors:  N Lila; A Carpentier; C Amrein; I Khalil-Daher; J Dausset; E D Carosella
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

3.  HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

Authors:  S Aractingi; N Briand; C Le Danff; M Viguier; H Bachelez; L Michel; L Dubertret; E D Carosella
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.

Authors:  E C Ibrahim; N Guerra; M J Lacombe; E Angevin; S Chouaib; E D Carosella; A Caignard; P Paul
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.

Authors:  B Riteau; N Rouas-Freiss; C Menier; P Paul; J Dausset; E D Carosella
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.

Authors:  C Menier; B Riteau; J Dausset; E D Carosella; N Rouas-Freiss
Journal:  Hum Immunol       Date:  2000-11       Impact factor: 2.850

7.  Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice.

Authors:  A Horuzsko; F Lenfant; D H Munn; A L Mellor
Journal:  Int Immunol       Date:  2001-03       Impact factor: 4.823

8.  Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.

Authors:  M Urosevic; M O Kurrer; J Kamarashev; B Mueller; W Weder; G Burg; R A Stahel; R Dummer; A Trojan
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

9.  HLA-G inhibits the allogeneic proliferative response.

Authors:  B Riteau; C Menier; I Khalil-Daher; C Sedlik; J Dausset; N Rouas-Freiss; E D Carosella
Journal:  J Reprod Immunol       Date:  1999-07       Impact factor: 4.054

10.  The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.

Authors:  D Saverino; M Fabbi; F Ghiotto; A Merlo; S Bruno; D Zarcone; C Tenca; M Tiso; G Santoro; G Anastasi; D Cosman; C E Grossi; E Ciccone
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

View more
  89 in total

1.  Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

Authors:  Kiave-Yune HoWangYin; Estibaliz Alegre; Marina Daouya; Benoit Favier; Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

Review 2.  HLA-G: a look back, a look forward.

Authors:  Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2010-11-19       Impact factor: 9.261

Review 3.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

4.  Trogocytosis of CD80 and CD86 by induced regulatory T cells.

Authors:  Peng Gu; Julia Fang Gao; Cheryl A D'Souza; Aleksandra Kowalczyk; Kuang-Yen Chou; Li Zhang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

5.  Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.

Authors:  Adriana Elizabeth Monsiváis-Urenda; Lourdes Baranda; Crisol Alvarez-Quiroga; Carlos Abud-Mendoza; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2010-12-29       Impact factor: 8.317

6.  HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction.

Authors:  Elnaz Mosaferi; Jafar Majidi; Mojdeh Mohammadian; Zohreh Babaloo; Amir Monfaredan; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-08-20

7.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

Review 8.  Dysfunction of antigen processing and presentation by dendritic cells in cancer.

Authors:  Joanna Bandola-Simon; Paul A Roche
Journal:  Mol Immunol       Date:  2018-04-05       Impact factor: 4.407

Review 9.  CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.

Authors:  Tamara Tilburgs; Jack L Strominger
Journal:  Am J Reprod Immunol       Date:  2013-02-23       Impact factor: 3.886

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.